NCT04701489 is a NA clinical trial of Splenic ultrasound in Covid19, sponsored by University of Minnesota.

Who is sponsoring NCT04701489?

NCT04701489 is sponsored by University of Minnesota.

What drugs are being tested in NCT04701489?

Interventions in NCT04701489: Splenic ultrasound.

What condition does NCT04701489 study?

NCT04701489 studies Covid19, Cytokine Storm, Inflammation.

Is NCT04701489 still recruiting?

NCT04701489 is currently completed. Last updated 3 May 2024.

Last reviewed 2024-05-03 · How we verify

NCT04701489

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

UNITE Study (UMN-GE) for COVID-19

Completed NA Last updated 3 May 2024

What this trial tests

NA trial testing Splenic ultrasound in Covid19 in 30 participants. Completed in 7 April 2021.

Timeline

14 January 2021

Primary endpoint
15 March 2021

7 April 2021

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	device feasibility
Enrollment	30
Start date	14 January 2021
Primary completion	15 March 2021
Estimated completion	7 April 2021
Sites	1 location across United States

Drugs / interventions tested

Splenic ultrasound

Conditions studied

Covid19 — all drugs for Covid19 →
Cytokine Storm — all drugs for Cytokine Storm →
Inflammation — all drugs for Inflammation →

Sponsor

University of Minnesota

Who can join

18 and older, any sex, with Covid19 or Cytokine Storm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research objective of the UNITE Study is to assess device feasibility of ultrasound application to the spleen to assess its effect on coronavirus disease 2019 (COVID-19) in a pilot study with an off-the-shelf ultrasound GE device originally used for diagnostic applications. Specific Aims: 1. Determine the feasibility of splenic ultrasound with an ultrasound device in affecting physiological markers in COVID-19 infected patients between an ultrasound group versus a control group for the primary analyses; and 2. Evaluate the potential capabilities of splenic ultrasound in affecting additional outcomes in COVID-19 infected patients in the ultrasound group compared to a control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04701489 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 3 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04701489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing